Call Now! 866-415-6313

4.8 Rating | 5,000+ Clients Treated Since 2016

Table of Contents

Is Suboxone Addictive? A Comprehensive Guide

Clinically Reviewed by: Charee Marquez, LMFT

Suboxone, a combination medication containing buprenorphine and naloxone, is a crucial component in treating opioid dependence. It belongs to a class of drugs known as opioid partial agonist-antagonists, designed to alleviate withdrawal symptoms and cravings while reducing the risk of misuse and diversion. Suboxone has revolutionized addiction treatment by offering a safer alternative to full opioid agonists like heroin and prescription painkillers.

What is Suboxone?

Suboxone is a medication primarily used in the treatment of opioid dependence and addiction. It is formulated as a combination of two active ingredients: buprenorphine and naloxone. Buprenorphine, a partial opioid agonist, acts on the same receptors in the brain as opioids but produces less euphoria and respiratory depression. Naloxone, an opioid antagonist, is included in Suboxone to deter misuse; if the medication is crushed and injected, naloxone precipitates withdrawal symptoms. This combination makes Suboxone an effective tool in medication-assisted treatment (MAT) for opioid addiction.

  • Active Ingredients: The active ingredients in Suboxone are buprenorphine and naloxone, each playing a distinct role in its mechanism of action. Buprenorphine, a partial opioid agonist, binds to opioid receptors in the brain, mitigating withdrawal symptoms and cravings without producing the intense euphoria associated with full agonists. Naloxone, an opioid antagonist, serves as a deterrent against misuse by blocking the effects of opioids if injected, discouraging abuse.
  • Common Applications of Suboxone: Suboxone is primarily used in the treatment of opioid dependence, serving as a cornerstone of medication-assisted treatment (MAT) programs. MAT combines pharmacotherapy with counseling and behavioral therapies to address the complex nature of opioid addiction comprehensively. Additionally, Suboxone may be prescribed for opioid withdrawal management, providing relief from symptoms such as nausea, muscle aches, and anxiety during detoxification.
  • Suboxone: A Prescription Medication: As a potent medication with the potential for misuse and diversion, Suboxone is available by prescription only. Healthcare providers must conduct a thorough assessment of patients before initiating treatment to determine the appropriate dosage and treatment plan. Patients should strictly adhere to their prescribed regimen and consult their healthcare provider before making any changes to their medication.
  • Suboxone Formulations: Suboxone is available in various formulations and dosages to accommodate individual patient needs and preferences. The most common formulations include sublingual films and tablets, each offering unique advantages in terms of administration and dosing flexibility. Dosages may range from lower strengths suitable for maintenance therapy to higher strengths for induction or stabilization.

Suboxone Types

Suboxone is available in various formulations, each designed to meet the specific needs of individuals undergoing treatment for opioid dependence. These formulations combine buprenorphine, a partial opioid agonist, with naloxone, an opioid antagonist, to deter misuse and reduce the risk of diversion. Understanding the different types of Suboxone formulations is essential for healthcare providers and patients to make informed treatment decisions.

1. Suboxone Film 8/2 mg:

Suboxone film is one of the most commonly prescribed formulations, favored for its convenience, ease of administration, and consistent dosing. Each sublingual film contains 8 mg of buprenorphine and 2 mg of naloxone, providing a balanced ratio that effectively manages withdrawal symptoms and cravings in many patients undergoing maintenance therapy.

  • Buprenorphine: As the primary active ingredient, buprenorphine acts as a partial agonist at the mu-opioid receptors, producing less euphoria and respiratory depression compared to full opioid agonists. Its long duration of action and high binding affinity contribute to its efficacy in suppressing withdrawal symptoms and reducing opioid cravings.
  • Naloxone: Naloxone serves as an opioid antagonist, blocking the effects of other opioids and mitigating the risk of misuse or diversion. When administered sublingually, naloxone has minimal systemic absorption, but it serves as a deterrent to injection or misuse of Suboxone by precipitating withdrawal symptoms if taken via non-approved routes.

Suboxone film is typically administered once daily, placed under the tongue until fully dissolved. The film formulation offers precise dosing, rapid onset of action, and consistent plasma levels, making it a preferred choice for many patients and healthcare providers.

2. Suboxone Tablets 2/0.5 mg:

Suboxone tablets provide an alternative formulation for individuals requiring lower doses or those with specific dosing requirements. Each tablet contains 2 mg of buprenorphine and 0.5 mg of naloxone, offering a lower starting dose for individuals with mild to moderate opioid dependence or those transitioning from higher doses of opioids.

  • Buprenorphine: The buprenorphine component in Suboxone tablets exerts its therapeutic effects by binding to opioid receptors in the brain, alleviating withdrawal symptoms, and reducing cravings. The lower dosage in these tablets allows for more flexible dosing regimens and individualized treatment approaches tailored to patient needs.
  • Naloxone: Naloxone in Suboxone tablets serves the same purpose as in the film formulation, acting as an opioid antagonist to deter misuse and prevent diversion. While naloxone has minimal bioavailability when taken sublingually, its presence provides an added layer of safety and reduces the likelihood of abuse.

Suboxone tablets are administered sublingually, similar to the film formulation, and are typically used as part of a comprehensive treatment plan that includes counseling, behavioral therapy, and support services.

Suboxone Film 8/2 mg:

Suboxone film is one of the most commonly prescribed formulations, favored for its convenience, ease of administration, and consistent dosing. Each sublingual film contains 8 mg of buprenorphine and 2 mg of naloxone, providing a balanced ratio that effectively manages withdrawal symptoms and cravings in many patients undergoing maintenance therapy.

  • Buprenorphine: As the primary active ingredient, buprenorphine acts as a partial agonist at the mu-opioid receptors, producing less euphoria and respiratory depression compared to full opioid agonists. Its long duration of action and high binding affinity contribute to its efficacy in suppressing withdrawal symptoms and reducing opioid cravings.
  • Naloxone: Naloxone serves as an opioid antagonist, blocking the effects of other opioids and mitigating the risk of misuse or diversion. When administered sublingually, naloxone has minimal systemic absorption, but it serves as a deterrent to injection or misuse of Suboxone by precipitating withdrawal symptoms if taken via non-approved routes.

Suboxone film is typically administered once daily, placed under the tongue until fully dissolved. The film formulation offers precise dosing, rapid onset of action, and consistent plasma levels, making it a preferred choice for many patients and healthcare providers.

Suboxone Brands and Street Names

Brand Names

  • Suboxone: The most widely recognized brand name for the buprenorphine/naloxone combination medication.
  • Subutex: Contains buprenorphine alone and may be prescribed in specific circumstances, such as during pregnancy.
  • Bunavail: Another formulation of buprenorphine/naloxone available in a buccal film formulation.

Street Names

  • Subs: Slang term for Suboxone, commonly used in informal settings or among individuals misusing the medication.
  • Stops: Another street name for Suboxone, referring to its ability to stop opioid cravings and withdrawal symptoms.

Suboxone Dosages and Guidelines

  • Dosage Variations: The appropriate dosage of Suboxone varies based on individual factors such as the severity of opioid dependence, previous treatment history, and response to therapy. Healthcare providers must conduct a comprehensive assessment to determine the initial and maintenance doses for each patient accurately.
  • Dosage Guidelines: The recommended starting dose of Suboxone typically ranges from 4 mg/1 mg to 8 mg/2 mg per day, depending on the patient’s level of opioid dependence and tolerance. Dosages may be adjusted gradually based on clinical response and tolerability, with regular monitoring to ensure optimal treatment outcomes.

Maximum Daily Dosage of Suboxone

While Suboxone dosages can be titrated upwards to achieve therapeutic effects, healthcare providers should exercise caution when prescribing higher doses. The maximum recommended daily dose of Suboxone is 24 mg/6 mg, beyond which the risk of adverse effects such as respiratory depression and overdose may increase.

Individualized Treatment

Each patient’s treatment plan should be individualized to address their unique needs, preferences, and response to therapy. Healthcare providers should consider factors such as concurrent medical conditions, psychosocial support, and treatment goals when determining the appropriate dosage and duration of Suboxone therapy.

Cautionary Notes

Patients should be educated about the importance of adhering to their prescribed dosage and regimen to optimize treatment outcomes. Abrupt discontinuation of Suboxone or misuse of the medication can lead to withdrawal symptoms, relapse, or overdose. Patients should seek medical advice before adjusting their medication or treatment plan.

Suboxone Uses

Suboxone is a versatile medication utilized in various aspects of opioid addiction treatment and management. Its effectiveness stems from its unique pharmacological properties and comprehensive approach to addressing both the physical and psychological aspects of addiction.

  • Treatment of Opioid Dependence: Suboxone is widely recognized for its role in treating opioid dependence, offering relief from withdrawal symptoms, reducing cravings, and stabilizing patients’ opioid use. When taken as prescribed, Suboxone occupies opioid receptors in the brain, effectively blocking the euphoric effects of other opioids. This mechanism not only helps individuals manage withdrawal symptoms but also reduces the reinforcing effects of opioids, making it easier for patients to abstain from illicit drug use. Additionally, Suboxone’s long-acting formulation provides sustained relief, allowing for once-daily dosing and minimizing fluctuations in opioid receptor occupancy.
  • Medication-Assisted Treatment (MAT): Medication-assisted treatment (MAT) programs integrate pharmacotherapy with counseling and behavioral therapies to provide comprehensive care for individuals with opioid addiction. Suboxone plays a central role in MAT by addressing the physiological aspects of addiction while simultaneously addressing the underlying psychological and behavioral factors contributing to substance use. In MAT, Suboxone is prescribed as part of a tailored treatment plan, with dosing adjusted based on individual response and therapeutic goals. The combination of medication and therapy empowers individuals to achieve and maintain long-term recovery while improving overall quality of life.
  • Opioid Withdrawal Management: Suboxone is also utilized for opioid withdrawal management, offering relief from the uncomfortable symptoms associated with discontinuation of opioid use. Withdrawal symptoms such as nausea, vomiting, diarrhea, muscle aches, and anxiety can be debilitating and may contribute to relapse if left untreated. Suboxone’s ability to alleviate these symptoms provides much-needed comfort and support during the detoxification process, facilitating a smoother transition to sobriety. Moreover, Suboxone’s longer duration of action compared to other medications used for withdrawal management allows for less frequent dosing and greater convenience for patients undergoing detoxification.

Suboxone Onset and Duration of Action

The onset of action of Suboxone, typically administered sublingually, can vary based on several factors, including the individual’s metabolism, dosage, and route of administration. Sublingual formulations generally start producing effects within 30 to 60 minutes after administration. However, variations may occur among individuals due to differences in absorption rates and physiological factors.

The duration of action of Suboxone is another critical aspect to consider. While the medication’s effects may last up to 24 to 72 hours, this timeframe can vary depending on multiple factors:

  • Dosage: Higher doses of Suboxone may prolong its duration of action, providing sustained relief from withdrawal symptoms and cravings.
  • Individual Metabolism: Variations in metabolism among individuals can influence how quickly Suboxone is metabolized and eliminated from the body. Factors such as liver function and genetic predispositions may contribute to differences in metabolic rates.
  • Treatment Duration: Prolonged use of Suboxone can lead to changes in tolerance and metabolism, affecting its duration of action over time. Long-term users may experience altered pharmacokinetics, necessitating adjustments to their treatment regimen.

It’s important for healthcare providers to monitor patients closely to ensure optimal dosing and efficacy while minimizing the risk of adverse effects or withdrawal symptoms between doses.

Suboxone Drug Detection Periods

Suboxone and its metabolites can be detected in various biological specimens, including urine, blood, saliva, and hair, through drug testing. The detection window for Suboxone varies depending on several factors, including the sensitivity and specificity of the testing method, as well as individual differences in metabolism and excretion rates.

  • Urine: Suboxone and its metabolites can typically be detected in urine samples for up to several days following the last dose. However, detection times may vary based on factors such as dose, frequency of use, and individual metabolism.
  • Blood: Blood tests for Suboxone are less common but can detect the drug and its metabolites for a shorter duration compared to urine testing, usually within a few hours to days after ingestion.
  • Saliva: Suboxone may be detectable in saliva samples for a shorter period compared to urine, typically ranging from a few hours to a couple of days after ingestion.
  • Hair: Hair testing for Suboxone can provide a longer detection window, potentially spanning several weeks to months, as drug metabolites become incorporated into hair follicles over time.

It’s important to note that while drug testing can provide valuable information about recent drug use, results should be interpreted in conjunction with clinical observations and patient history to ensure accurate assessment and appropriate management.

Efficacy of Suboxone

  • Mechanism of Action: The mechanism of action of Suboxone is multifaceted, involving both buprenorphine and naloxone components. Buprenorphine, a partial opioid agonist, binds to opioid receptors in the brain, activating them to a lesser extent than full agonists like heroin or oxycodone. Naloxone, an opioid antagonist, blocks the effects of opioids if injected, reducing the risk of misuse and diversion.
  • Opioid Dependency Management: Suboxone is highly effective in managing opioid dependence, offering a combination of symptom relief, craving reduction, and functional improvement. Its long-acting formulation allows for once-daily dosing, promoting treatment adherence and continuity of care. When used as part of a comprehensive treatment plan, Suboxone can help individuals achieve and maintain long-term recovery from opioid addiction.

Suboxone Controlled Substance Classification

Schedule Classification

Suboxone is classified as a Schedule III controlled substance under the Controlled Substances Act, indicating a moderate to low potential for abuse and dependence relative to Schedule I and II substances. Despite its favorable safety profile, Suboxone can still be misused, diverted, or abused, necessitating strict regulation and oversight.

Prescription Regulations

Prescribing and dispensing Suboxone are subject to stringent regulations aimed at preventing misuse, diversion, and overdose. Healthcare providers must complete specialized training and obtain a waiver from the Drug Enforcement Administration (DEA) to prescribe buprenorphine-containing medications like Suboxone. Patients receiving Suboxone therapy must undergo regular monitoring and compliance checks to ensure safe and effective treatment outcomes.

Opioid Warning

While Suboxone is generally safe and well-tolerated when used as prescribed, it is not without risks. Common side effects include nausea, constipation, headache, dizziness, and drowsiness, which typically resolve with continued treatment. However, more serious adverse effects such as respiratory depression, allergic reactions, and liver toxicity may occur in rare cases and require immediate medical attention.

Safe Storage and Disposal Practices for Suboxone

  • Storage Guidelines: Suboxone should be stored securely in a cool, dry place away from direct sunlight and moisture to maintain its potency and integrity. It should be kept out of reach of children, pets, and unauthorized individuals to prevent accidental ingestion or misuse. Unused or expired medication should be promptly disposed of following recommended guidelines.
  • Disposal Methods: Unused or expired Suboxone should be disposed of properly to prevent unintentional exposure or environmental contamination. Patients can return unused medication to authorized collection sites, participate in drug take-back programs, or follow FDA-recommended disposal methods such as mixing the medication with an undesirable substance (e.g., coffee grounds) and sealing it in a container before disposal in the trash.

Side Effects and Risks of Suboxone

  • Short-term Side Effects: Short-term side effects of Suboxone are typically mild to moderate in severity and tend to diminish with continued use. Common side effects include nausea, constipation, headache, dizziness, drowsiness, sweating, and dry mouth. Patients should report any persistent or bothersome side effects to their healthcare provider for further evaluation and management.
  • Long-term Side Effects: Long-term use of Suboxone may be associated with certain risks, including physical dependence, tolerance, and withdrawal symptoms upon discontinuation. Patients should work closely with their healthcare provider to taper off Suboxone gradually when appropriate to minimize the risk of withdrawal and relapse. Regular monitoring and follow-up appointments are essential to ensure safe and effective long-term treatment outcomes.

Alcohol Use and Suboxone

Combining Suboxone with alcohol or other central nervous system depressants can increase the risk of respiratory depression, sedation, and overdose. Patients should avoid alcohol while taking Suboxone and disclose any concurrent medication use to their healthcare provider to prevent potentially harmful drug interactions. Healthcare providers should educate patients about the risks of combined use and encourage abstinence from alcohol and other substances during treatment.

Suboxone Addiction and Overdose Risks

Addiction Potential

While Suboxone is intended to treat opioid dependence, it is not entirely devoid of addiction potential. Some individuals may develop psychological or physical dependence on Suboxone, necessitating careful monitoring and evaluation during treatment. Healthcare providers should assess patients for signs of misuse, diversion, or escalating opioid use and intervene promptly to prevent addiction or overdose.

Overdose Symptoms

Suboxone overdose can occur when the medication is misused, taken in higher doses than prescribed, or combined with other substances. Symptoms of overdose may include respiratory depression, extreme drowsiness, confusion, slurred speech, pinpoint pupils, and loss of consciousness. If overdose is suspected, emergency medical assistance should be sought immediately to prevent life-threatening complications.

Escalation to Harder Drugs

Role of Other Opioids

Despite its effectiveness in treating opioid dependence, Suboxone is not a cure-all solution and may not address all underlying issues contributing to addiction. Some individuals may continue to experience cravings, withdrawal symptoms, or psychological distress despite Suboxone therapy, increasing the risk of relapse or escalation to harder drugs. Comprehensive treatment approaches that address both physical and psychological aspects of addiction are essential for long-term recovery.

Recognizing Signs of Misuse

Healthcare providers and loved ones should be vigilant in recognizing signs of Suboxone misuse or diversion, such as frequent requests for early refills, unexplained changes in behavior or mood, and social isolation. Patients should be encouraged to communicate openly with their healthcare provider about any concerns or challenges they may encounter during treatment to receive appropriate support and intervention.

Treatment Options for Suboxone

  1. Medication-Assisted Treatment (MAT) Programs

Medication-assisted treatment (MAT) programs represent a gold standard in the management of opioid addiction, offering a comprehensive and multifaceted approach to recovery. These programs integrate pharmacotherapy with various therapeutic modalities and support services to address the complex nature of opioid dependence.

Pharmacotherapy:

    • Suboxone as a Key Component: Suboxone, a combination of buprenorphine and naloxone, is a cornerstone of MAT for opioid addiction. Buprenorphine, a partial opioid agonist, alleviates withdrawal symptoms and reduces cravings without producing the euphoric effects associated with full opioid agonists. Naloxone, an opioid antagonist, deters misuse by precipitating withdrawal if the medication is tampered with or injected.
    • Effectiveness of Buprenorphine: Buprenorphine has demonstrated high efficacy in reducing opioid use, promoting retention in treatment, and preventing relapse. Its long-acting formulation allows for once-daily dosing, enhancing treatment adherence and patient convenience. By stabilizing opioid receptors in the brain, buprenorphine restores neurochemical balance, mitigates withdrawal symptoms, and attenuates the reinforcing effects of opioids.
  1. Counseling and Behavioral Therapies:

Counseling and behavioral therapies are integral components of MAT, addressing the psychological, social, and behavioral aspects of addiction. These therapeutic interventions aim to enhance coping skills, facilitate insight and self-awareness, and promote sustainable behavior change.

    • Cognitive-Behavioral Therapy (CBT): CBT is a widely utilized therapeutic approach in addiction treatment, focusing on identifying and modifying maladaptive thoughts, beliefs, and behaviors associated with substance use. By challenging cognitive distortions, developing coping strategies, and enhancing problem-solving skills, CBT empowers individuals to cope with triggers, cravings, and stressors without resorting to substance use.
    • Contingency Management: Contingency management is a behavioral intervention that utilizes positive reinforcement to incentivize abstinence and adherence to treatment goals. Through the provision of tangible rewards, such as vouchers, prizes, or privileges, contingent on drug-free behaviors, individuals are motivated to engage in pro-recovery activities and maintain sobriety.
    • Motivational Interviewing (MI): MI is a collaborative, client-centered approach that seeks to explore and resolve ambivalence towards change. By eliciting and amplifying intrinsic motivation for recovery, addressing barriers to change, and fostering self-efficacy, MI facilitates the development of commitment and readiness for positive behavior change.

Insurance Coverage for Suboxone Treatment

Many insurance plans cover the cost of Suboxone therapy and other addiction treatment services, making treatment more accessible to individuals in need. Patients should check with their insurance provider to determine coverage options, including deductibles, copayments, and in-network providers. Healthcare providers and treatment facilities can assist patients in navigating insurance coverage and accessing affordable treatment options.

Call California Prime Recovery Today!

If you or someone you care about is grappling with addiction, there’s no need to face it alone. California Prime Recovery is here to help. Reach out to us at 866-208-2390 to take the first step toward healing. Our dedicated team provides compassionate support and personalized treatment options to guide you on your journey to recovery. Don’t let addiction hold you back any longer. Call us today and let’s start this journey together towards a healthier, brighter future. Also, check out our blogs posted weekly on Medium.

FAQs

While Suboxone can lead to physical dependence, when used as prescribed under the supervision of a healthcare provider, the risk of addiction is minimal compared to full opioid agonists.

Common side effects of Suboxone include nausea, constipation, headache, and dizziness. Long-term use may increase the risk of respiratory depression and opioid dependence.

Suboxone has a half-life of approximately 24 to 60 hours, meaning it can remain detectable in the body for several days after the last dose. Factors such as metabolism, dosage, and frequency of use can influence the duration of action and drug detection periods.

Combining Suboxone with alcohol or other central nervous system depressants can increase the risk of respiratory depression, sedation, and overdose. Patients should avoid alcohol while taking Suboxone and consult their healthcare provider before using any other medications or substances.

If you are struggling with opioid dependence and experiencing withdrawal symptoms or cravings, Suboxone treatment may be beneficial. Speak to a qualified healthcare provider to discuss your treatment options and determine the most appropriate course of action for your individual needs.

Come work with us

Get Help Now

Admission Coordinators are available 24/7.
Take Control Of Your Life and Call Now.